Safety and efficacy of rogaratinib in combination with atezolizumab in cisplatin-ineligible patients (pts) with locally advanced or metastatic urothelial cancer (UC) and FGFR mRNA overexpression in the phase Ib/II FORT-2 study Meeting Abstract
| Authors: | Rosenberg, J. E.; Gajate, P.; Morales-Barrera, R.; Lee, J. L.; Necchi, A.; Penel, N.; Zagonel, V.; Sierecki, M. R.; Bao, W. C.; Zhou, Y. H.; Ellinghaus, P.; Sweis, R. F. |
| Abstract Title: | Safety and efficacy of rogaratinib in combination with atezolizumab in cisplatin-ineligible patients (pts) with locally advanced or metastatic urothelial cancer (UC) and FGFR mRNA overexpression in the phase Ib/II FORT-2 study |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120602269 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.4521 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4521 -- Source: Wos |
